EQUASENS (EQS.PA) Stock Fundamental Analysis
EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR
EQS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 10 industry peers in the Health Care Technology industry. EQS gets an excellent profitability rating and is at the same time showing great financial health properties. EQS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year EQS was profitable.
In the past year EQS had a positive cash flow from operations.
In the past 5 years EQS has always been profitable.
EQS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
EQS has a better Return On Assets (9.10%) than 80.00% of its industry peers.
The Return On Equity of EQS (15.65%) is better than 90.00% of its industry peers.
The Return On Invested Capital of EQS (12.02%) is better than 90.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EQS is significantly above the industry average of 8.54%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROIC | 12.02% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
The Profit Margin of EQS (16.72%) is better than 90.00% of its industry peers.
In the last couple of years the Profit Margin of EQS has remained more or less at the same level.
The Operating Margin of EQS (20.18%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of EQS has declined.
EQS has a Gross Margin of 68.77%. This is in the lower half of the industry: EQS underperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EQS is creating value.
The number of shares outstanding for EQS remains at a similar level compared to 1 year ago.
The number of shares outstanding for EQS has been increased compared to 5 years ago.
The debt/assets ratio for EQS has been reduced compared to a year ago.
2.2 Solvency
EQS has an Altman-Z score of 4.55. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of EQS (4.55) is better than 90.00% of its industry peers.
EQS has a debt to FCF ratio of 1.29. This is a very positive value and a sign of high solvency as it would only need 1.29 years to pay back of all of its debts.
EQS has a better Debt to FCF ratio (1.29) than 70.00% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that EQS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.12, EQS is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Altman-Z | 4.55 |
ROIC/WACC1.58
WACC7.63%
2.3 Liquidity
EQS has a Current Ratio of 1.21. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
EQS has a Current ratio (1.21) which is comparable to the rest of the industry.
EQS has a Quick Ratio of 1.10. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
EQS has a Quick ratio (1.10) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.02%.
The Earnings Per Share has been growing slightly by 5.12% on average over the past years.
EQS shows a decrease in Revenue. In the last year, the revenue decreased by -1.37%.
Measured over the past years, EQS shows a small growth in Revenue. The Revenue has been growing by 6.45% on average per year.
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
3.2 Future
Based on estimates for the next years, EQS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.54% on average per year.
The Revenue is expected to grow by 7.74% on average over the next years.
EPS Next Y27.31%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.26%
Revenue Next 2Y11.8%
Revenue Next 3Y9.29%
Revenue Next 5Y7.74%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.82, EQS is valued on the expensive side.
Based on the Price/Earnings ratio, EQS is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.30, EQS is valued a bit cheaper.
The Price/Forward Earnings ratio is 17.04, which indicates a rather expensive current valuation of EQS.
70.00% of the companies in the same industry are more expensive than EQS, based on the Price/Forward Earnings ratio.
EQS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.76.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.82 | ||
| Fwd PE | 17.04 |
4.2 Price Multiples
EQS's Enterprise Value to EBITDA ratio is in line with the industry average.
70.00% of the companies in the same industry are more expensive than EQS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.02 | ||
| EV/EBITDA | 12.48 |
4.3 Compensation for Growth
EQS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of EQS may justify a higher PE ratio.
A more expensive valuation may be justified as EQS's earnings are expected to grow with 18.54% in the coming years.
PEG (NY)0.76
PEG (5Y)4.06
EPS Next 2Y18.54%
EPS Next 3YN/A
5. Dividend
5.1 Amount
EQS has a Yearly Dividend Yield of 2.53%.
EQS's Dividend Yield is comparable with the industry average which is at 4.20.
EQS's Dividend Yield is comparable with the S&P500 average which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
5.2 History
On average, the dividend of EQS grows each year by 8.00%, which is quite nice.
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
51.86% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
EQS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.86%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPA:EQS (7/11/2025, 7:00:00 PM)
49.75
-0.45 (-0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners10.49%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap754.71M
Analysts80
Price Target58.14 (16.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.86%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.2%
PT rev (3m)-18.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.82 | ||
| Fwd PE | 17.04 | ||
| P/S | 3.48 | ||
| P/FCF | 21.02 | ||
| P/OCF | 15.87 | ||
| P/B | 3.26 | ||
| P/tB | 9.25 | ||
| EV/EBITDA | 12.48 |
EPS(TTM)2.39
EY4.8%
EPS(NY)2.92
Fwd EY5.87%
FCF(TTM)2.37
FCFY4.76%
OCF(TTM)3.13
OCFY6.3%
SpS14.29
BVpS15.26
TBVpS5.38
PEG (NY)0.76
PEG (5Y)4.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROCE | 14.76% | ||
| ROIC | 12.02% | ||
| ROICexc | 14.31% | ||
| ROICexgc | 35.95% | ||
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% | ||
| FCFM | 16.57% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexcg growth 3Y-25.09%
ROICexcg growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Debt/EBITDA | 0.48 | ||
| Cap/Depr | 79.39% | ||
| Cap/Sales | 5.37% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.41% | ||
| Profit Quality | 99.11% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 4.55 |
F-Score5
WACC7.63%
ROIC/WACC1.58
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
EPS Next Y27.31%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
Revenue Next Year9.26%
Revenue Next 2Y11.8%
Revenue Next 3Y9.29%
Revenue Next 5Y7.74%
EBIT growth 1Y-20.84%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year71.53%
EBIT Next 3Y25.63%
EBIT Next 5YN/A
FCF growth 1Y-8.64%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-17.61%
OCF growth 3Y0.02%
OCF growth 5Y3.18%